Mitomycin

CAS 50-07-7 8 FDA-DMF suppliersSmall Molecule

Overview

Mitomycin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL105).

API suppliers (7)

Suppliers of Mitomycin backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
  • TAPI NL BV1 active DMF
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
  • TAPI NL BV1 active DMF
  • KYOWA HAKKO KOGYO CO LTD
  • MICROBIOPHARM JAPAN CO LTD

Patent & exclusivity (US)

Per the FDA Orange Book (22 approved US products), the latest listed US patent on Mitomycin expires 20 Jan 2031 and exclusivity 11 Jun 2028. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate
Canonical SMILES
CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N
InChIKey
NWIBSHFKIJFRCO-WUDYKRTCSA-N

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo